Stable neuronal Map2 expression has previously been demonstrated to be altered in the aging process [34], [35] as well as neurological disorders such as Alzheimer's disease [36], [37] and Downs Syndrome [38]. This evidence concerns the gene MAP2 and Alzheimer disease.